Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Short-Term Debt issuances (2016 - 2025)

Bruker's Short-Term Debt issuances history spans 11 years, with the latest figure at -$15.0 million for Q4 2025.

  • For Q4 2025, Short-Term Debt issuances fell 108.48% year-over-year to -$15.0 million; the TTM value through Dec 2025 reached $750.5 million, down 39.97%, while the annual FY2025 figure was $750.5 million, 39.97% down from the prior year.
  • Short-Term Debt issuances reached -$15.0 million in Q4 2025 per BRKRP's latest filing, down from $457.3 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $804.4 million in Q2 2024 to a low of -$15.0 million in Q4 2025.